{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T22:52:02Z","timestamp":1791240722777,"version":"4.1.0"},"reference-count":90,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100008209","name":"University at Buffalo","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008209","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100013355","name":"University at Buffalo Center for Protein Therapeutics","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100013355","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Pharmacology & Therapeutics"],"published-print":{"date-parts":[[2026,11]]},"DOI":"10.1016\/j.pharmthera.2026.109091","type":"journal-article","created":{"date-parts":[[2026,7,26]],"date-time":"2026-07-26T22:04:44Z","timestamp":1785103484000},"page":"109091","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Mathematical modeling of T cell exhaustion in the tumor microenvironment"],"prefix":"10.1016","volume":"287","author":[{"given":"Toluwalope E.","family":"Adeniyi-Aogo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne M.","family":"Talkington","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"16","key":"10.1016\/j.pharmthera.2026.109091_bb0005","doi-asserted-by":"crossref","first-page":"R921","DOI":"10.1016\/j.cub.2020.06.081","article-title":"The tumor microenvironment","volume":"30","author":"Anderson","year":"2020","journal-title":"Current Biology"},{"issue":"23","key":"10.1016\/j.pharmthera.2026.109091_bb0010","doi-asserted-by":"crossref","first-page":"5030","DOI":"10.1158\/1078-0432.CCR-21-2390","article-title":"Molecular pathways and mechanisms of LAG3 in cancer therapy","volume":"28","author":"Andrews","year":"2022","journal-title":"Clinical Cancer Research"},{"issue":"1","key":"10.1016\/j.pharmthera.2026.109091_bb0015","doi-asserted-by":"crossref","DOI":"10.1038\/srep24169","article-title":"A stochastic model for immunotherapy of cancer","volume":"6","author":"Baar","year":"2016","journal-title":"Scientific Reports"},{"issue":"1","key":"10.1016\/j.pharmthera.2026.109091_bb0020","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1146\/annurev-immunol-090222-110914","article-title":"T cell exhaustion","volume":"42","author":"Baessler","year":"2024","journal-title":"Annual Review of Immunology"},{"key":"10.1016\/j.pharmthera.2026.109091_bb0025","series-title":"Springer Proceedings in Complexity","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1007\/978-3-319-00395-5_1","article-title":"Aggregation and emergence in agent-based models: A Markov chain approach","author":"Banisch","year":"2013"},{"key":"10.1016\/j.pharmthera.2026.109091_bb0030","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.660944","article-title":"Hypoxia supports differentiation of terminally exhausted CD8 T cells","volume":"12","author":"Bannoud","year":"2021","journal-title":"Frontiers in Immunology"},{"issue":"4","key":"10.1016\/j.pharmthera.2026.109091_bb0035","article-title":"Towards multiscale modeling of the CD8+ T cell response to viral infections","volume":"11","author":"Baral","year":"2019","journal-title":"Wiley Interdisciplinary Reviews: Systems Biology and Medicine"},{"key":"10.1016\/j.pharmthera.2026.109091_bb0040","doi-asserted-by":"crossref","DOI":"10.1016\/j.jtbi.2022.111207","article-title":"Mathematical investigation into the role of macrophage heterogeneity on the temporal and spatio-temporal dynamics of non-small cell lung cancers","volume":"549","author":"Bartha","year":"2022","journal-title":"Journal of Theoretical Biology"},{"issue":"1","key":"10.1016\/j.pharmthera.2026.109091_bb0045","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-020-58600-8","article-title":"Integrative network modeling reveals mechanisms underlying T cell exhaustion","volume":"10","author":"Bolouri","year":"2020","journal-title":"Scientific Reports"},{"issue":"2","key":"10.1016\/j.pharmthera.2026.109091_bb0050","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pcbi.1004731","article-title":"Quantifying clonal and subclonal passenger mutations in Cancer evolution","volume":"12","author":"Bozic","year":"2016","journal-title":"PLoS Computational Biology"},{"key":"10.1016\/j.pharmthera.2026.109091_bb0055","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2023.1151632","article-title":"Exhausted T cells hijacking the cancer-immunity cycle: Assets and liabilities","volume":"14","author":"Brunell","year":"2023","journal-title":"Frontiers in Immunology"},{"issue":"5","key":"10.1016\/j.pharmthera.2026.109091_bb0060","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1109\/JPROC.2021.3136715","article-title":"The hallmarks of mathematical oncology","volume":"110","author":"Bull","year":"2022","journal-title":"Proceedings of the IEEE"},{"issue":"1","key":"10.1016\/j.pharmthera.2026.109091_bb0065","doi-asserted-by":"crossref","DOI":"10.1038\/s41540-024-00415-8","article-title":"Hybridizing mechanistic modeling and deep learning for personalized survival prediction after immune checkpoint inhibitor immunotherapy","volume":"10","author":"Butner","year":"2024","journal-title":"npj Systems Biology and Applications"},{"issue":"1","key":"10.1016\/j.pharmthera.2026.109091_bb0070","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1002\/cyto.a.24496","article-title":"Single cell multiomic analysis of T cell exhaustion in vitro","volume":"101","author":"Corselli","year":"2022","journal-title":"Cytometry, Part A"},{"key":"10.1016\/j.pharmthera.2026.109091_bb0075","first-page":"615","article-title":"Agent-Based modeling in systems pharmacology","volume":"4","author":"Cosgrove","year":"2015","journal-title":"CPT: Pharmacometrics & Systems Pharmacology"},{"key":"10.1016\/j.pharmthera.2026.109091_bb0080","first-page":"84280","volume":"12","author":"Cunha","year":"2023","journal-title":"Oxygen levels at the time of activation determine T cell persistence and immunotherapeutic efficacy"},{"issue":"1","key":"10.1016\/j.pharmthera.2026.109091_bb0085","doi-asserted-by":"crossref","DOI":"10.1186\/s13662-021-03621-4","article-title":"Mathematical analysis of a cancer model with time-delay in tumor-immune interaction and stimulation processes","volume":"2021","author":"Dehingia","year":"2021","journal-title":"Advances in Difference Equations"},{"issue":"11","key":"10.1016\/j.pharmthera.2026.109091_bb0090","doi-asserted-by":"crossref","DOI":"10.1063\/5.0006567","article-title":"Analysis of tumor-immune dynamics in a delayed dendritic cell therapy model","volume":"30","author":"Dickman","year":"2020","journal-title":"Chaos: An Interdisciplinary Journal of Nonlinear Science"},{"issue":"1","key":"10.1016\/j.pharmthera.2026.109091_bb0095","doi-asserted-by":"crossref","first-page":"55","DOI":"10.3934\/dcdsb.2014.19.55","article-title":"Mathematical modeling on helper T cells in a tumor immune system","volume":"19","author":"Dong","year":"2014","journal-title":"Discrete & Continuous Dynamical Systems - B"},{"issue":"1","key":"10.1016\/j.pharmthera.2026.109091_bb0100","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1146\/annurev.immunol.22.012703.104803","article-title":"The three Es of Cancer Immunoediting","volume":"22","author":"Dunn","year":"2004","journal-title":"Annual Review of Immunology"},{"key":"10.1016\/j.pharmthera.2026.109091_bb0105","series-title":"Branching process models of cancer","first-page":"1","author":"Durrett","year":"2015"},{"issue":"1","key":"10.1016\/j.pharmthera.2026.109091_bb0110","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1007\/s11538-010-9526-3","article-title":"Interactions between the immune system and cancer: A brief review of non-spatial mathematical models","volume":"73","author":"Eftimie","year":"2011","journal-title":"Bulletin of Mathematical Biology"},{"issue":"30","key":"10.1016\/j.pharmthera.2026.109091_bb0115","doi-asserted-by":"crossref","first-page":"4934","DOI":"10.2174\/1381612819666131125150434","article-title":"Mathematical modeling of tumor growth and treatment","volume":"20","author":"Enderling","year":"2014","journal-title":"Current Pharmaceutical Design"},{"issue":"2","key":"10.1016\/j.pharmthera.2026.109091_bb0120","first-page":"215","article-title":"A model of the effects of cancer cell motility and cellular adhesion properties on tumour-immune dynamics","volume":"34","author":"Frascoli","year":"2017","journal-title":"Mathematical Medicine and Biology"},{"issue":"7","key":"10.1016\/j.pharmthera.2026.109091_bb0125","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0069008","article-title":"Boolean network model for Cancer pathways: Predicting carcinogenesis and targeted therapy outcomes","volume":"8","author":"Fumi\u00e3","year":"2013","journal-title":"PLoS One"},{"issue":"6","key":"10.1016\/j.pharmthera.2026.109091_bb0130","doi-asserted-by":"crossref","first-page":"1221","DOI":"10.1016\/j.bpj.2017.02.008","article-title":"A sigmoid functional response emerges when cytotoxic T lymphocytes start killing fresh target cells","volume":"112","author":"Gadhamsetty","year":"2017","journal-title":"Biophysical Journal"},{"issue":"8","key":"10.1016\/j.pharmthera.2026.109091_bb0135","doi-asserted-by":"crossref","first-page":"2127","DOI":"10.1158\/0008-5472.CAN-17-2649","article-title":"Spatial heterogeneity and evolutionary dynamics modulate time to recurrence in continuous and adaptive cancer therapies","volume":"78","author":"Gallaher","year":"2018","journal-title":"Cancer Research"},{"issue":"134","key":"10.1016\/j.pharmthera.2026.109091_bb0140","doi-asserted-by":"crossref","DOI":"10.1098\/rsif.2017.0320","article-title":"A computational multiscale agent-based model for simulating spatio-temporal tumour immune response to PD1 and PDL1 inhibition","volume":"14","author":"Gong","year":"2017","journal-title":"Journal of the Royal Society Interface"},{"issue":"6","key":"10.1016\/j.pharmthera.2026.109091_bb0145","first-page":"380","article-title":"Quantitative systems pharmacology: An exemplar model-building workflow with applications in cardiovascular, metabolic, and oncology drug development","volume":"8","author":"Helmlinger","year":"2019","journal-title":"CPT: Pharmacometrics & Systems Pharmacology"},{"issue":"4","key":"10.1016\/j.pharmthera.2026.109091_bb0150","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1016\/j.cels.2024.03.004","article-title":"Integrating multiplexed imaging and multiscale modeling identifies tumor phenotype conversion as a critical component of therapeutic T cell efficacy","volume":"15","author":"Hickey","year":"2024","journal-title":"Cell Systems"},{"key":"10.1016\/j.pharmthera.2026.109091_bb0155","series-title":"Mathematical modeling of T-cell exhaustion and PD-1 blockade in chronic infections","author":"Jagadish","year":"2015"},{"issue":"1","key":"10.1016\/j.pharmthera.2026.109091_bb0160","doi-asserted-by":"crossref","DOI":"10.1093\/oxfimm\/iqad006","article-title":"The current state and future of T-cell exhaustion research","volume":"4","author":"Jenkins","year":"2023","journal-title":"Oxford Open Immunology"},{"issue":"6","key":"10.1016\/j.pharmthera.2026.109091_bb0165","doi-asserted-by":"crossref","DOI":"10.1038\/cddis.2015.162","article-title":"T-cell exhaustion in the tumor microenvironment","volume":"6","author":"Jiang","year":"2015","journal-title":"Cell Death & Disease"},{"issue":"1","key":"10.1016\/j.pharmthera.2026.109091_bb0170","doi-asserted-by":"crossref","DOI":"10.1038\/s41540-024-00336-6","article-title":"Mitigating non-genetic resistance to checkpoint inhibition based on multiple states of immune exhaustion","volume":"10","author":"Kareva","year":"2024","journal-title":"npj Systems Biology and Applications"},{"issue":"1","key":"10.1016\/j.pharmthera.2026.109091_bb0175","doi-asserted-by":"crossref","DOI":"10.1007\/s00285-023-01934-4","article-title":"Stochastic differential equation modelling of cancer cell migration and tissue invasion","volume":"87","author":"Katsaounis","year":"2023","journal-title":"Journal of Mathematical Biology"},{"key":"10.1016\/j.pharmthera.2026.109091_bb0180","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1016\/j.amc.2014.10.009","article-title":"Stability and bifurcation analysis of delay induced tumor immune interaction model","volume":"248","author":"Khajanchi","year":"2014","journal-title":"Applied Mathematics and Computation"},{"issue":"10","key":"10.1016\/j.pharmthera.2026.109091_bb0185","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pcbi.1002742","article-title":"Modeling protective anti-tumor immunity via preventative Cancer vaccines using a hybrid agent-based and delay differential equation approach","volume":"8","author":"Kim","year":"2012","journal-title":"PLoS Computational Biology"},{"issue":"3","key":"10.1016\/j.pharmthera.2026.109091_bb0190","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1016\/j.jprocont.2012.12.006","article-title":"Optimization of chemotherapy and immunotherapy: In silico analysis using pharmacokinetic-pharmacodynamic and tumor growth models","volume":"23","author":"Kiran","year":"2013","journal-title":"Journal of Process Control"},{"issue":"3","key":"10.1016\/j.pharmthera.2026.109091_bb0195","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1007\/s002850050127","article-title":"Modeling immunotherapy of the tumor - immune interaction","volume":"37","author":"Kirschner","year":"1998","journal-title":"Journal of Mathematical Biology"},{"issue":"2","key":"10.1016\/j.pharmthera.2026.109091_bb0200","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1007\/BF02460644","article-title":"Nonlinear dynamics of immunogenic tumors: Parameter estimation and global bifurcation analysis","volume":"56","author":"Kuznetsov","year":"1994","journal-title":"Bulletin of Mathematical Biology"},{"issue":"5","key":"10.1016\/j.pharmthera.2026.109091_bb0205","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1007\/s11538-025-01433-1","article-title":"The impact of T-cell exhaustion dynamics on tumour-immune interactions and tumour growth","volume":"87","author":"Lai","year":"2025","journal-title":"Bulletin of Mathematical Biology"},{"issue":"9","key":"10.1016\/j.pharmthera.2026.109091_bb0210","doi-asserted-by":"crossref","DOI":"10.1007\/s11538-025-01507-0","article-title":"Modeling combination therapies and T cell exhaustion dynamics in the tumor under immune checkpoint blockade","volume":"87","author":"Lai","year":"2025","journal-title":"Bulletin of Mathematical Biology"},{"issue":"1","key":"10.1016\/j.pharmthera.2026.109091_bb0215","doi-asserted-by":"crossref","DOI":"10.1038\/s41540-025-00578-y","article-title":"Ordinary differential equation model of cancer-associated fibroblast heterogeneity predicts treatment outcomes","volume":"11","author":"Lee","year":"2025","journal-title":"npj Systems Biology and Applications"},{"issue":"3","key":"10.1016\/j.pharmthera.2026.109091_bb0220","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1002\/cpt.2040","article-title":"Model-based cellular kinetic analysis of chimeric antigen receptor-T cells in humans","volume":"109","author":"Liu","year":"2021","journal-title":"Clinical Pharmacology and Therapeutics"},{"issue":"12","key":"10.1016\/j.pharmthera.2026.109091_bb0225","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2022-005360","article-title":"Computational model of CAR T-cell immunotherapy dissects and predicts leukemia patient responses at remission, resistance, and relapse","volume":"10","author":"Liu","year":"2022","journal-title":"Journal for Immunotherapy of Cancer"},{"key":"10.1016\/j.pharmthera.2026.109091_bb0230","doi-asserted-by":"crossref","DOI":"10.1016\/j.canlet.2024.217076","article-title":"Metabolic reprogramming in tumor immune microenvironment: Impact on immune cell function and therapeutic implications","volume":"597","author":"Liu","year":"2024","journal-title":"Cancer Letters"},{"issue":"4","key":"10.1016\/j.pharmthera.2026.109091_bb0235","doi-asserted-by":"crossref","DOI":"10.1002\/wsbm.1484","article-title":"Modeling immune cell behavior across scales in cancer","volume":"12","author":"Makaryan","year":"2020","journal-title":"WIREs Systems Biology and Medicine"},{"key":"10.1016\/j.pharmthera.2026.109091_bb0240","article-title":"Simulating CD8 T cell exhaustion: A comprehensive approach","author":"Manrique-Rinc\u00f3n","year":"2024","journal-title":"Cold Spring Harbor Laboratory"},{"key":"10.1016\/j.pharmthera.2026.109091_bb0245","doi-asserted-by":"crossref","DOI":"10.1016\/j.chaos.2022.112738","article-title":"Stochastic differential equation models for tumor population growth","volume":"164","author":"Mansour","year":"2022","journal-title":"Chaos, Solitons & Fractals"},{"issue":"1","key":"10.1016\/j.pharmthera.2026.109091_bb0250","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.jtbi.2011.03.022","article-title":"A hybrid multi-compartment model of granuloma formation and T cell priming in tuberculosis","volume":"280","author":"Marino","year":"2011","journal-title":"Journal of Theoretical Biology"},{"issue":"S2","key":"10.1016\/j.pharmthera.2026.109091_bb0255","article-title":"An introduction to immunology and immunopathology","volume":"14","author":"Marshall","year":"2018","journal-title":"Allergy, Asthma and Clinical Immunology"},{"issue":"12","key":"10.1016\/j.pharmthera.2026.109091_bb0260","doi-asserted-by":"crossref","first-page":"6371","DOI":"10.3390\/ijms22126371","article-title":"A mathematical description of the bone marrow dynamics during CAR T-cell therapy in B-cell childhood acute lymphoblastic leukemia","volume":"22","author":"Mart\u00ednez-Rubio","year":"2021","journal-title":"International Journal of Molecular Sciences"},{"issue":"11","key":"10.1016\/j.pharmthera.2026.109091_bb0265","doi-asserted-by":"crossref","first-page":"210787","DOI":"10.1098\/rsos.210787","article-title":"A hybrid PDE-ABM model for viral dynamics with application to SARS-CoV-2 and influenza","volume":"8","author":"Marzban","year":"2021","journal-title":"Royal Society Open Science"},{"issue":"1","key":"10.1016\/j.pharmthera.2026.109091_bb0270","doi-asserted-by":"crossref","DOI":"10.1038\/s41540-024-00438-1","article-title":"Spatial interactions modulate tumor growth and immune infiltration","volume":"10","author":"Marzban","year":"2024","journal-title":"npj Systems Biology and Applications"},{"key":"10.1016\/j.pharmthera.2026.109091_bb0275","series-title":"Adaptive dynamics: A geometrical study of the consequences of nearly faithful reproduction","author":"Metz","year":"1996"},{"key":"10.1016\/j.pharmthera.2026.109091_bb0280","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2024.1363144","article-title":"A review of mechanistic learning in mathematical oncology","volume":"15","author":"Metzcar","year":"2024","journal-title":"Frontiers in Immunology"},{"issue":"3","key":"10.1016\/j.pharmthera.2026.109091_bb0285","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1038\/s41590-019-0312-6","article-title":"Subsets of exhausted CD8+ T cells differentially mediate tumor control and respond to checkpoint blockade","volume":"20","author":"Miller","year":"2019","journal-title":"Nature Immunology"},{"issue":"4","key":"10.1016\/j.pharmthera.2026.109091_bb0290","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1016\/j.jtbi.2003.11.024","article-title":"A mathematical model for chronic myelogenous leukemia (CML) and T cell interaction","volume":"227","author":"Moore","year":"2004","journal-title":"Journal of Theoretical Biology"},{"issue":"6422","key":"10.1016\/j.pharmthera.2026.109091_bb0295","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1038\/362758a0","article-title":"Virus persistence in acutely infected immunocompetent mice by exhaustion of antiviral cytotoxic effector T cells","volume":"362","author":"Moskophidis","year":"1993","journal-title":"Nature"},{"issue":"6","key":"10.1016\/j.pharmthera.2026.109091_bb0300","doi-asserted-by":"crossref","first-page":"1442","DOI":"10.1002\/cpt.3451","article-title":"Quantitative systems pharmacology models: Potential tools for advancing drug development for rare diseases","volume":"116","author":"Neves-Zaph","year":"2024","journal-title":"Clinical Pharmacology & Therapeutics"},{"issue":"1","key":"10.1016\/j.pharmthera.2026.109091_bb0305","doi-asserted-by":"crossref","first-page":"37","DOI":"10.3390\/pr7010037","article-title":"Multiscale agent-based and hybrid modeling of the tumor immune microenvironment","volume":"7","author":"Norton","year":"2019","journal-title":"Processes"},{"key":"10.1016\/j.pharmthera.2026.109091_bb0310","series-title":"Spatiotemporal dynamics of tumor - CAR T-cell interaction following local administration in solid cancers","author":"Owens","year":"2024"},{"issue":"1\u20132","key":"10.1016\/j.pharmthera.2026.109091_bb0315","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1007\/s12190-019-01292-9","article-title":"Mathematical modeling and dynamic analysis of anti-tumor immune response","volume":"62","author":"Pang","year":"2020","journal-title":"Journal of Applied Mathematics and Computing"},{"key":"10.1016\/j.pharmthera.2026.109091_bb0320","first-page":"1661","article-title":"A mathematical model of immune response to tumor invasion","volume":"2003","author":"de Pillis","year":"2003","journal-title":"Computational Fluid and Solid Mechanics"},{"key":"10.1016\/j.pharmthera.2026.109091_bb0325","article-title":"Mathematical models and computational approaches in CAR-T therapeutics","volume":"16","author":"Putignano","year":"2025","journal-title":"Frontiers in Immunology"},{"issue":"1","key":"10.1016\/j.pharmthera.2026.109091_bb0330","first-page":"115","article-title":"Hybrid models of tumor growth","volume":"3","author":"Rejniak","year":"2011","journal-title":"Wiley Interdisciplinary Reviews: Systems Biology and Medicine"},{"key":"10.1016\/j.pharmthera.2026.109091_bb0335","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2014\/982978","article-title":"Delay differential model for tumour-immune response with Chemoimmunotherapy and optimal control","volume":"2014","author":"Rihan","year":"2014","journal-title":"Computational and Mathematical Methods in Medicine"},{"issue":"21","key":"10.1016\/j.pharmthera.2026.109091_bb0340","doi-asserted-by":"crossref","first-page":"2707","DOI":"10.3390\/math9212707","article-title":"Dynamics of tumor-immune system with random noise","volume":"9","author":"Rihan","year":"2021","journal-title":"Mathematics"},{"issue":"1","key":"10.1016\/j.pharmthera.2026.109091_bb0345","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-021-83612-3","article-title":"Ex vivo modelling of PD-1\/PD-L1 immune checkpoint blockade under acute, chronic, and exhaustion-like conditions of T-cell stimulation","volume":"11","author":"Roberts","year":"2021","journal-title":"Scientific Reports"},{"key":"10.1016\/j.pharmthera.2026.109091_bb0350","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.jtbi.2011.10.027","article-title":"A mathematical model of tumor-immune interactions","volume":"294","author":"Robertson-Tessi","year":"2012","journal-title":"Journal of Theoretical Biology"},{"issue":"9","key":"10.1016\/j.pharmthera.2026.109091_bb0355","doi-asserted-by":"crossref","first-page":"1527","DOI":"10.1038\/s41590-023-01578-y","article-title":"Hallmarks of CD8+ T cell dysfunction are established within hours of tumor antigen encounter before cell division","volume":"24","author":"Rudloff","year":"2023","journal-title":"Nature Immunology"},{"issue":"7","key":"10.1016\/j.pharmthera.2026.109091_bb0360","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pcbi.1010254","article-title":"Simulations of tumor growth and response to immunotherapy by coupling a spatial agent-based model with a whole-patient quantitative systems pharmacology model","volume":"18","author":"Ruiz-Martinez","year":"2022","journal-title":"PLoS Computational Biology"},{"issue":"8","key":"10.1016\/j.pharmthera.2026.109091_bb0365","doi-asserted-by":"crossref","first-page":"2274","DOI":"10.3390\/cancers12082274","article-title":"Mechanisms of T-cell exhaustion in pancreatic Cancer","volume":"12","author":"Saka","year":"2020","journal-title":"Cancers"},{"issue":"7","key":"10.1016\/j.pharmthera.2026.109091_bb0370","doi-asserted-by":"crossref","DOI":"10.3390\/pharmaceutics13071016","article-title":"The role of mathematical models in Immuno-oncology: Challenges and future perspectives","volume":"13","author":"Sancho-Araiz","year":"2021","journal-title":"Pharmaceutics"},{"issue":"1","key":"10.1016\/j.pharmthera.2026.109091_bb0375","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-023-38760-z","article-title":"Computational reactive\u2013diffusive modeling for stratification and prognosis determination of patients with breast cancer receiving Olaparib","volume":"13","author":"Schettini","year":"2023","journal-title":"Scientific Reports"},{"issue":"1","key":"10.1016\/j.pharmthera.2026.109091_bb0380","doi-asserted-by":"crossref","DOI":"10.1038\/s41392-021-00823-w","article-title":"T cell receptor (TCR) signaling in health and disease","volume":"6","author":"Shah","year":"2021","journal-title":"Signal Transduction and Targeted Therapy"},{"issue":"11","key":"10.1016\/j.pharmthera.2026.109091_bb0385","doi-asserted-by":"crossref","DOI":"10.1007\/s11538-023-01207-7","article-title":"Modeling the development of cellular exhaustion and tumor-immune stalemate","volume":"85","author":"Simmons","year":"2023","journal-title":"Bulletin of Mathematical Biology"},{"issue":"5","key":"10.1016\/j.pharmthera.2026.109091_bb0390","first-page":"285","article-title":"Tisagenlecleucel model-based cellular kinetic analysis of chimeric antigen receptor\u2013T cells","volume":"8","author":"Stein","year":"2019","journal-title":"CPT: Pharmacometrics & Systems Pharmacology"},{"issue":"1","key":"10.1016\/j.pharmthera.2026.109091_bb0395","doi-asserted-by":"crossref","DOI":"10.1038\/s43856-022-00110-x","article-title":"Spatial structure impacts adaptive therapy by shaping intra-tumoral competition","volume":"2","author":"Strobl","year":"2022","journal-title":"Communications Medicine"},{"issue":"5","key":"10.1016\/j.pharmthera.2026.109091_bb0400","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1007\/s11538-017-0263-8","article-title":"Ordinary differential equation models for adoptive immunotherapy","volume":"80","author":"Talkington","year":"2018","journal-title":"Bulletin of Mathematical Biology"},{"issue":"1","key":"10.1016\/j.pharmthera.2026.109091_bb0405","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1038\/s41568-021-00413-6","article-title":"Overcoming TGF\u03b2-mediated immune evasion in cancer","volume":"22","author":"Tauriello","year":"2022","journal-title":"Nature Reviews Cancer"},{"key":"10.1016\/j.pharmthera.2026.109091_bb0410","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.869768","article-title":"PD-1 immune checkpoint blockade and PSGL-1 inhibition synergize to reinvigorate exhausted T cells","volume":"13","author":"Viramontes","year":"2022","journal-title":"Frontiers in Immunology"},{"key":"10.1016\/j.pharmthera.2026.109091_bb0415","article-title":"Conducting a virtual clinical trial in HER2-negative breast Cancer using a quantitative systems pharmacology model with an epigenetic modulator and immune checkpoint inhibitors","volume":"8","author":"Wang","year":"2020","journal-title":"Frontiers in Bioengineering and Biotechnology"},{"issue":"22","key":"10.1016\/j.pharmthera.2026.109091_bb0420","doi-asserted-by":"crossref","DOI":"10.3390\/ijms252212223","article-title":"Metabolic reprogramming of immune cells in the tumor microenvironment","volume":"25","author":"Wang","year":"2024","journal-title":"International Journal of Molecular Sciences"},{"issue":"4","key":"10.1016\/j.pharmthera.2026.109091_bb0425","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1016\/j.jhep.2019.05.015","article-title":"TOX promotes the exhaustion of antitumor CD8+ T cells by preventing PD1 degradation in hepatocellular carcinoma","volume":"71","author":"Wang","year":"2019","journal-title":"Journal of Hepatology"},{"issue":"8","key":"10.1016\/j.pharmthera.2026.109091_bb0430","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1038\/nri3862","article-title":"Molecular and cellular insights into T cell exhaustion","volume":"15","author":"Wherry","year":"2015","journal-title":"Nature Reviews Immunology"},{"issue":"10","key":"10.1016\/j.pharmthera.2026.109091_bb0435","first-page":"720","article-title":"A review of mathematical models for tumor dynamics and treatment resistance evolution of solid tumors","volume":"8","author":"Yin","year":"2019","journal-title":"CPT: Pharmacometrics & Systems Pharmacology"},{"issue":"4","key":"10.1016\/j.pharmthera.2026.109091_bb0440","doi-asserted-by":"crossref","first-page":"923","DOI":"10.20892\/j.issn.2095-3941.2020.0338","article-title":"Exhausted T cells and epigenetic status","volume":"17","author":"Zeng","year":"2020","journal-title":"Cancer Biology & Medicine"},{"issue":"1","key":"10.1016\/j.pharmthera.2026.109091_bb0445","doi-asserted-by":"crossref","DOI":"10.1038\/s41389-023-00482-2","article-title":"Deep learning identifies a T-cell exhaustion-dependent transcriptional signature for predicting clinical outcomes and response to immune checkpoint blockade","volume":"12","author":"Zhang","year":"2023","journal-title":"Oncogenesis"},{"issue":"10","key":"10.1016\/j.pharmthera.2026.109091_bb0450","doi-asserted-by":"crossref","DOI":"10.1002\/adtp.202200130","article-title":"A computational model of cytokine release syndrome during CAR T-cell therapy","volume":"5","author":"Zhang","year":"2022","journal-title":"Advanced Therapeutics"}],"container-title":["Pharmacology & Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S016372582600118X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S016372582600118X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,6]],"date-time":"2026-09-06T20:22:51Z","timestamp":1788726171000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S016372582600118X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,11]]},"references-count":90,"alternative-id":["S016372582600118X"],"URL":"https:\/\/doi.org\/10.1016\/j.pharmthera.2026.109091","relation":{},"ISSN":["0163-7258"],"issn-type":[{"value":"0163-7258","type":"print"}],"subject":[],"published":{"date-parts":[[2026,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Mathematical modeling of T cell exhaustion in the tumor microenvironment","name":"articletitle","label":"Article Title"},{"value":"Pharmacology & Therapeutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.pharmthera.2026.109091","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"109091"}}